Ramírez Molina V R, Masa Jiménez J F, Gómez de Terreros Caro F J, Corral Peñafiel J
Pulmonary and Sleep Medicine, Regional General Hospital N.2 of the Mexican Social Security Institute (IMSS), Querétaro, Mexico.
Division of Pulmonary Medicine, San Pedro de Alcántara Hospital, Cáceres, Spain; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.
Pulmonology. 2020 Nov-Dec;26(6):370-377. doi: 10.1016/j.pulmoe.2020.05.012. Epub 2020 Jun 16.
Obesity hypoventilation syndrome (OHS) is an undesirable consequence of obesity, defined as daytime hypoventilation, sleep disorder breathing and obesity; during the past few years the prevalence of extreme obesity has markedly increased worldwide consequently increasing the prevalence of OHS. Patients with OHS have a lower quality of life and a higher risk of unfavourable cardiometabolic consequences. Early diagnosis and effective treatment can lead to significant improvement in patient outcomes; therefore, such data has noticeably raised interest in the management and treatment of this sleep disorder. This paper will discuss the findings on the main current treatment modalities OHS will be discussed.
肥胖低通气综合征(OHS)是肥胖的不良后果,定义为白天通气不足、睡眠呼吸障碍和肥胖;在过去几年中,极端肥胖在全球的患病率显著增加,因此OHS的患病率也随之上升。OHS患者的生活质量较低,发生不良心脏代谢后果的风险较高。早期诊断和有效治疗可显著改善患者预后;因此,此类数据明显提高了人们对这种睡眠障碍的管理和治疗的兴趣。本文将讨论当前主要治疗方式的研究结果,并对OHS进行讨论。